Stabilized peptoid-peptide hybrids and uses thereof

US10197575B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10197575-B2
Application numberUS-201515300451-A
CountryUS
Kind codeB2
Filing dateMar 31, 2015
Priority dateMar 31, 2014
Publication dateFeb 5, 2019
Grant dateFeb 5, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The current invention pertains to stabilized peptoids or peptoid-peptide hybrids. The peptoids or peptoid-peptide hybrids are stabilized by side chain-side to side chain linkages and/or backbone cyclization. The current invention also provides a positional library scanning method for identification of peptoids or peptoid-peptide hybrids having a desired biological activity.

First claim

Opening claim text (preview).

We claim: 1. A stapled peptoid comprising a plurality of N-substituted glycines, wherein at least two of the N-substituted glycines are linked to each other by an intramolecular cross-link between the N-substitutions, and wherein the length and geometry of the cross-link pre-organizes the peptoid into a desired conformation. 2. A stapled peptoid-peptide hybrid comprising a plurality of amino acids and a plurality of N-substituted glycines, wherein at least two residues from the plurality of amino acids and the plurality of N-substituted glycines are linked to each other by an intramolecular cross-link, and wherein the length and geometry of the intramolecular cross-link provides stability to the peptoid-peptide hybrid. 3. The stapled peptoid-peptide hybrid of claim 2 , wherein two N-substituted glycine residues or two amino acid residues are linked to each other by the intramolecular cross-link. 4. The stapled peptoid-peptide hybrid of claim 2 , wherein an N-substituted glycine residue is linked to an amino acid residue by the intramolecular cross-link. 5. The stapled peptoid-peptide hybrid of claim 2 , wherein the peptoid-peptide hybrid is a cyclic peptoid-peptide hybrid, the cyclic peptoid-peptide hybrid comprising a plurality of alternating peptoid-peptide sequences, wherein the peptoid-peptide sequences form at least two antiparallel beta-strands. 6. The stapled peptoid-peptide hybrid of claim 2 , further comprising substitutions on the amino acid side chains or the N-substitutions on glycines, wherein the substitutions further stabilize the peptoid-peptide hybrids. 7. The stapled peptoid-peptide hybrid of claim 2 , wherein one or more of the substitutions are selected from the groups listed in Table 1 or shown in FIG. 9 , and wherein the substitutions may be the same or different. 8. The stapled peptoid-peptide hybrid of claim 2 , wherein the peptoid-peptide hybrid is selected from formula I, formula II, formula III, formula IV, formula V, formula VI, formula VII, formula VIII, formula IX, formula X, formula XI, or formula XII. 9. The stapled peptoid-peptide hybrid of claim 8 , wherein one or more of the R groups are selected from the groups listed in Table 1 or shown in FIG. 9 . 10. The stapled peptoid-peptide hybrid of claim 2 , wherein the peptoid-peptide hybrid is that of FIG. 1A , optionally including the attached linker, or optionally including the attached linker and resin. 11. The stapled peptoid-peptide hybrid of claim 10 , wherein one or more of the R groups (R 1 , R 2 , R 3 , or R 4 ) are selected from the groups listed in Table 1 or shown in FIG. 9 . 12. The stapled peptoid-peptide hybrid of claim 2 , wherein the peptoid-peptide hybrid is that of FIG. 1B or 1C . 13. The stapled peptoid-peptide hybrid of claim 2 , wherein the peptoid-peptide hybrid is that of FIG. 3 , FIG. 4 , FIG. 5 , or FIG. 6 . 14. The stapled peptoid-peptide hybrid of claim 13 , wherein one or more of the variable side chains are selected from the groups listed in Table 1 or shown in FIG. 9 . 15. The stapled peptoid-peptide hybrid of claim 2 , wherein the peptoid-peptide hybrid is that of FIG. 7 or FIG. 8 , optionally including the attached resin. 16. A positional library of the peptoid-peptide hybrid of claim 2 .

Assignees

Inventors

Classifications

  • C07K14/00Primary

    Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title

  • C07K7/64Primary

    Cyclic peptides containing only normal peptide links · CPC title

  • Methods of identifying protein-protein interactions in protein mixtures · CPC title

  • involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)} · CPC title

  • Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10197575B2 cover?
The current invention pertains to stabilized peptoids or peptoid-peptide hybrids. The peptoids or peptoid-peptide hybrids are stabilized by side chain-side to side chain linkages and/or backbone cyclization. The current invention also provides a positional library scanning method for identification of peptoids or peptoid-peptide hybrids having a desired biological activity.
Who is the assignee on this patent?
H Lee Moffitt Cancer Ct & Res, Univ South Florida
What technology area does this patent fall under?
Primary CPC classification C07K14/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).